Repligen RGEN
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 12th percentile, 5-year average 111.3x
#2898 of 2994 stocks by PE (1 = cheapest)
Above its usual level · 73rd percentile, 5-year average 4.7x
#4399 of 5331 stocks by PB (1 = cheapest)
Above its usual level · 65th percentile, 5-year average 13.1x
#4608 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 5.13 | – | 4.69 | 73% (pricier than usual) | #4399 of 5331 (1 = cheapest) |
| PE | -799.00 | 155.00 | 111.31 | 12% (cheaper than usual) | #2898 of 2994 (1 = cheapest) |
| PS | 13.31 | 10.45 | 13.05 | 65% (pricier than usual) | #4608 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on RGEN.
Sign in to join the discussion.